Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 2/2010

01-02-2010 | original article

Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography

Auteurs: E-S Tan, P. A. Van der Vleuten, G. A. J. Jessurun, R. A. Tio, F. Zijlstra, I. C. Van Gelder

Gepubliceerd in: Netherlands Heart Journal | Uitgave 2/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background. Little is known about the diagnostic accuracy of global LV function assessment by electromechanical endocardial mapping (EEM). The aim of the present study was to determine the relationship between global left ventricular (LV) function measured by EEM and biplane left ventricular contrast angiography (LVA) after ST-elevation myocardial infarction (STEMI).
Methods. Thirty-seven patients underwent LVA and EEM during routine coronary angiography four months after primary percutaneous intervention for STEMI. Global LV function parameters were available from both techniques in all patients. LVA was regarded as reference standard.
Results. All procedures were carried out without adverse events. Average age was 55±10 years and 84% were male. EEM showed an overestimation of end-diastolic volume (EDV) and end-systolic volume (ESV) of 6.5 ml and 25.5 ml, respectively. Correlation (r) was 0.84 (p<0.001) for EDV and 0.74 (p<0.001) for ESV. Average left ventricular ejection fraction (LVEF) measured by EEM was 17.2% point (±11.3% point) lower compared with LVA (r=0.69, p<0.001).
Conclusion. Although global functional parameters by EEM correlated well with LVA, the relatively large differences in terms of absolute values for ventricular volumes and LVEF render the two techniques non-interchangeable for global LV-function-data. (Neth Heart J 2010;18:72–77.)
Literatuur
1.
go back to reference Van der Vleuten PA, Rasoul S, Huurnink W, Van der Horst IC, Slart RH, Reiffers S, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2008;8:4. Van der Vleuten PA, Rasoul S, Huurnink W, Van der Horst IC, Slart RH, Reiffers S, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2008;8:4.
2.
go back to reference Moise A, Bourassa MG, Theroux P, Taeymans Y, Pasternac A, Campeau L, et al. Prognostic significance of progression of coronary artery disease. Am J Cardiol. 1985;55:941–6. Moise A, Bourassa MG, Theroux P, Taeymans Y, Pasternac A, Campeau L, et al. Prognostic significance of progression of coronary artery disease. Am J Cardiol. 1985;55:941–6.
3.
go back to reference Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645–57. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645–57.
4.
go back to reference Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6.
5.
go back to reference Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–302. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–302.
6.
go back to reference Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol. 2007;100:1094–8. Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol. 2007;100:1094–8.
7.
go back to reference Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–21. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–21.
8.
go back to reference Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–42. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–42.
9.
go back to reference Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198–202. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198–202.
10.
go back to reference Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with sixmonth follow-up. J Am Coll Cardiol. 2003;42:2063–9. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with sixmonth follow-up. J Am Coll Cardiol. 2003;42:2063–9.
11.
go back to reference Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:2138–43. Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:2138–43.
12.
go back to reference Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953–60. Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953–60.
13.
go back to reference Grothues F, Wolfram O, Fantoni C, Boenigk H, Gotte A, Tempelmann C, et al. Volume measurement by CARTO compared with cardiac magnetic resonance. Europace. 2006;8:37–41. Grothues F, Wolfram O, Fantoni C, Boenigk H, Gotte A, Tempelmann C, et al. Volume measurement by CARTO compared with cardiac magnetic resonance. Europace. 2006;8:37–41.
14.
go back to reference Van Langenhove G, Hamburger JN, Smits PC, Albertal M, Onderwater E, Kay IP, et al. Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. Am Heart J. 2000;140:596–602. Van Langenhove G, Hamburger JN, Smits PC, Albertal M, Onderwater E, Kay IP, et al. Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. Am Heart J. 2000;140:596–602.
15.
go back to reference Hirsch A, Nijveldt R, Van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial. Am Heart J. 2006;152:434–41. Hirsch A, Nijveldt R, Van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial. Am Heart J. 2006;152:434–41.
16.
go back to reference Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
Metagegevens
Titel
Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography
Auteurs
E-S Tan
P. A. Van der Vleuten
G. A. J. Jessurun
R. A. Tio
F. Zijlstra
I. C. Van Gelder
Publicatiedatum
01-02-2010
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 2/2010
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03091741

Andere artikelen Uitgave 2/2010

Netherlands Heart Journal 2/2010 Naar de uitgave